Supply of Varicella Vaccine
Value
Estimated—
Awarded—
Who already wins at this buyer
Firms with recorded awards from Health Service Executive (HSE) in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| JED Pharma LTD | 3 | €700,000 | 2026-08-27 |
| Celltrion Healthcare Ireland Limited. | 2 | €1,800,000 | 2026-08-27 |
| Roche Diagnostics Limited | 1 | €40,000,000 | 2026-09-18 |
| Nutricia Ireland Limited | Healthcare 21 | 1 | €34,000,000 | 2026-08-20 |
| Medray Imaging Systems Ltd | Trasmore Limited T/A Dental Medical Ireland | 1 | €9,189,000 | 2026-08-21 |
Full buyer profile: what Health Service Executive (HSE) buys and who wins it →
CPV codes
33651600 Medical equipment & pharmaceuticalsDescription
The Health Service Executive (HSE) intends to enter Direct Negotiations for the supply and delivery to the HSE of a Varicella Vaccine in accordance with the National Immunisation Advisory Committee Guidelines of Ireland (NIAC). This is following the Health Service Executive (HSE) inviting DPS tenderers to express their interest in submitting a tender whereby only one supplier responded with their intention to submit a tender. This is a VEAT notice to indicate that the HSE intends utilize EU public procurement directive Art 32.2(b) (iii) negotiated procedure without prior publication in the following case. (B) Where works, supplies or services can be supplied only by a particular economic operator for any of the following reasons: (iii) competition is absent for technical reasons. This notice is to indicate that the HSE intends to contract with this supplier as they are currently the sole agent in Ireland approved to supply of the Varicella Vaccine. This VEAT notice is subject to a 2 weeks standstill period after which contract execution will occur.
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-10-01 | Supply and Delivery of Live Attenuated Influenza Vaccine (LAIV) 2026/2027 Flu Season | Health Service Executive (HSE) IE | 91% |
| 2026-08-27 | Supply and Delivery of 6 in 1 (Diphtheria, Tetanus, acellular Pertussis, Hepatitis B, Inactivated Polio Vaccine, Haemophilus Influenza Type B Conjugate) Vaccine | Health Service Executive (HSE) IE | 91% |
| 2026-06-08 | Supply and Delivery of Hepatitis B Recombinant Vaccine (Adsorbed) for Dialysis and Pre Dialysis Adult Patients | Health Service Executive (HSE) IE | 91% |
| 2026-08-26 | Supply and Delivery of Human Seasonal Trivalent Influenza Vaccines | Health Service Executive (HSE) IE | 90% |
| 2026-08-27 | Temperature Controlled Supply Chain Management Services | Health Service Executive (HSE) IE | 89% |
| 2026-10-20 | Dynamic Purchasing System Qualification for the Provision of Diagnostics and Imaging Equipment | Health Service Executive (HSE) IE | 89% |